Mucin-based vaccines and cancer.
Fricker
J
J
D000595:Amino Acid Sequence; D001500:BCG Vaccine / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology; D017321:Clinical Trials, Phase I as Topic; D005822:Genetic Vectors; D006433:Hemocyanins / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000235:genetics / Q000494:pharmacology*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D012503:Saponins / Q000737:chemistry / Q000494:pharmacology; D014614:Vaccines, Synthetic / Q000627:therapeutic use*; D014615:Vaccinia / Q000235:genetics*
D001500:BCG Vaccine; D018396:Mucin-1; D012503:Saponins; D014614:Vaccines, Synthetic; C078785:saponin QA-21V1; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin